The approach to coronary bifurcation treatment and its outcomes in Poland: The single center experience

Witkowski, Adam; Gil, Robert; Bojko, Krystian; Rzeszowski, Bartłomiej; Jalali, Rakesh; Górny, Jerzy; Bil, Jacek

doi:10.5603/cj.a2017.0057

Cited by 5 publications

(5 citation statements)

References 26 publications

(37 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prevalence of death is less than 1%. 11,12 These numbers are similar to the results of our study. Therefore, the limitations of the different strategies for PCI treatment in bifurcations are not related to the early outcomes, but to late outcomes.…”

Section: Journal Of Transcatheter Interventionssupporting

confidence: 91%

Percutaneous coronary intervention in bifurcation lesions: independent predictors of in-hospital death

Oliveira¹,

Correia²,

Oliveira³

2019

J Transcat Intervent

View full text Add to dashboard Cite

Background: Bifurcation lesions remain a challenge and little is known about the characteristics and outcomes of percutaneous coronary intervention over the last decade with the increasing use of drug-eluting stents. The objective of this study was to identify the patient profile and the in-hospital outcomes as well as the predictors of in-hospital death over time. Methods: An observational, retrospective study that evaluated patients undergoing percutaneous coronary intervention for bifurcation lesions between 2006 and 2016. Patients were divided into three groups: 2006-2008 (Group 1), 2009-2011 (Group 2), and 2012-2016 (Group 3). We used multiple logistic regression analysis to identify independent predictors of in-hospital death. Results: A total of 36,608 patients were included, and Group 3 patients were older, with a higher number of comorbidities, more stable clinical presentation and lesions treated with longer stent length and smaller stent size. The success of the procedure was higher (96.1% vs. 97.4% vs. 98.1%; p<0.0001) and the mortality lower (1.2% vs. 0.7% vs. 0.6%; p<0.0001) in the most recently treated group. In the multiple logistic regression analysis, female sex, left main coronary artery lesions, primary percutaneous coronary intervention, rescue percutaneous coronary intervention, procedures performed between 2006-2008 and use of glycoprotein IIb/IIIa inhibitors were variables independently associated with in-hospital mortality. Conclusions: Female sex, acute clinical presentation, emergency percutaneous coronary intervention, and greater anatomical complexity were associated with in-hospital mortality in patients undergoing coronary bifurcation treatment. Advances in contemporary treatment possibly contributed to the clinical outcome improvement in these patients.

show abstract

Section: Journal Of Transcatheter Interventionssupporting

confidence: 91%

Percutaneous coronary intervention in bifurcation lesions: independent predictors of in-hospital death

Oliveira¹,

Correia²,

Oliveira³

2019

J Transcat Intervent

View full text Add to dashboard Cite

show abstract

“…Covering the SB ostium, which is facilitated by Stentys DES architecture, could decrease the need for second stent implantation. Indeed, the rate of SB stenting in the current study was low and comparable to other dedicated bifurcation DES such as Bioss LIM (Balton, Warsaw, Poland) . notwithstanding, it was lower than in other previously tested stents .…”

Section: Discussionsupporting

confidence: 56%

Safety and efficacy of self‐apposing Stentys drug‐eluting stent in left main coronary artery PCI: Multicentre LM‐STENTYS registry

Wańha

Mielczarek

Smołka

et al. 2018

Cathet Cardio Intervent

View full text Add to dashboard Cite

Background There is a paucity of data on left main (LM) percutaneous coronary intervention (PCI) therapy with dedicated DES platforms. The LM‐STENTYS is a multicenter registry aimed at evaluating clinical outcome after PCI of LM performed with a self‐apposing Stentys DES implantation. Methods The registry consists of 175 consecutive patients treated with Stentys DES implanted to LM. The primary endpoint was the composite of major adverse cardiac and cerebral events (MACCE) defined as cardiac death, myocardial infarction (MI), target lesion revascularization (TLR), and stroke assessed after 1 year. The secondary endpoint was stent thrombosis (ST) at 1 year. Results The median age was 69 years (IQR, 62–78 years). Acute coronary syndrome (ACS) was the presenting diagnosis in 117 (66.9%) patients [74 (63.2%) unstable angina, 31 (26.5%) NSTEMI, 12 (10.3%) STEMI] and stable angina (SA) was present in 58 (33.1%) patients. The median SYNTAX score was 23.0 (IQR, 18.7–32.2) in the SA group and 25.0 (IQR, 20.0–30.7) in the ACS group. During 1‐year follow‐up in the SA group two (3.4%) MACCE occurred, both of them were cardiac deaths. In ACS patients there were 19 (16.2%) MACCE [9 (7.7%) cardiac deaths, 11 (9.4%) MIs, 11(9.4%) TLR, 1(0.9%) stroke]. Altogether, three (1.7%) cases of acute ST were noted, all of them in ACS subset. Conclusion LM PCI using self‐apposing Stentys DES showed favorable clinical outcomes at 1‐year in patients with SA. Events of ST in the ACS group warrant further research.

show abstract

“…The first BiOSS ® stent was a bare metal one (stainless steel), but shortly after, a paclitaxel-eluting version was introduced into the market -the BiOSS Expert ® stent (CE Mark 2010), and in 2012 the sirolimus-eluting BiOSS LIM ® stent was developed. The obtained results in registries and clinical trials [8][9][10][11][12][13] as well as in everyday practice were satisfactory [14][15][16], but still a means of improvement has been sought. Therefore, a cobalt-chromium sirolimus-eluting version has been developed, i.e.…”

Section: Introductionmentioning

confidence: 99%

First-in-man study of dedicated bifurcation cobalt-chromium sirolimus-eluting stent BiOSS LIM C® — three-month results

Gil

Bil²,

Witkowski

et al. 2018

Kardiol Pol

Self Cite

View full text Add to dashboard Cite

show abstract

The approach to coronary bifurcation treatment and its outcomes in Poland: The single center experience

Cited by 5 publications

References 26 publications

Percutaneous coronary intervention in bifurcation lesions: independent predictors of in-hospital death

Percutaneous coronary intervention in bifurcation lesions: independent predictors of in-hospital death

Safety and efficacy of self‐apposing Stentys drug‐eluting stent in left main coronary artery PCI: Multicentre LM‐STENTYS registry

First-in-man study of dedicated bifurcation cobalt-chromium sirolimus-eluting stent BiOSS LIM C® — three-month results

Contact Info

Product

Resources

About